Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Over 50 partner sites now using ‘Login with Doximity’ to verify physicians Network now over 220,000 members or 30% of US physicians
Glancy Binkow & Goldberg LLP announces that a class action lawsuit has been filed in the United States District Court, Northern District of California on behalf of all those who purchased...
STEVENSON, Md., March 12, 2013 (GLOBE NEWSWIRE) -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the...
NEW YORK, March 8, 2013 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP filed a class action complaint in the United States District Court for the Northern District of California on behalf...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. (“Epocrates” or the...
SAN MATEO, Calif., Jan. 23, 2013 (GLOBE NEWSWIRE) -- Patient safety is a top priority for all clinicians, yet preventable drug errors are still prevalent throughout the United States. In the past...
The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Epocrates, Inc. in Connection with the Sale of the Company to athenahealth...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Epocrates, Inc. (“Epocrates” or the...
NEW YORK, Jan. 17, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Epocrates, Inc. ("Epocrates" or the "Company") (Nasdaq:EPOC) of claims of breaches of fiduciary duty and other...
Ryan & Maniskas, LLP Announces Investigation of Epocrates, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.p...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
